WASHINGTON - The Biotechnology Industry Organization sent Sen. Edward Kennedy a letter applauding his proposal to delete the Breakthrough Drug Advisory Council from health care reform legislation, and supporting, with reservations, his decision to substitute a study of the broad impact of new medical technologies.

Kennedy earlier this month deleted the breakthrough council from legislation under consideration by the Labor and Human Resource Committee, which he chairs. (See BioCentury Extra, May 19, 1994). In its